Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Gamma-aminobutyric acid receptor agonists, aquaporin-4, and neuromyelitis optica: a potential link.
Type I IFN receptor controls activated TYK2 in the nucleus: Implications for EAE therapy.
Progress in multiple sclerosis genetics.
EphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injury.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
A pilot randomized trial of progressive resistance exercise augmented by neuromuscular electrical stimulation for people with Multiple Sclerosis who use walking aids.
Human endogenous retrovirus-K contributes to motor neuron disease.
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.
Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis.
Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.
A role for HLA-DRB1*1101 and DRB1*0801 in cognitive ability and its decline with age.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.
Predictors of recurrence following an initial episode of transverse myelitis.
The Outlook for Alemtuzumab in Multiple Sclerosis.
Microglia - performers of the 21st century.
PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: A comparison between [(11)C]CIC and [(11)C]MeDAS.
Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
Non-human primate models of multiple sclerosis.
Botulinum Toxin Treatment of Spasticity in Adults and Children.
Long-term effects of intrathecal baclofen in multiple sclerosis.
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.
Pages
« first
‹ previous
…
534
535
536
537
538
539
540
541
542
…
next ›
last »